Story perspectives

BRCA Mutation Carriers Face High Ovarian Cancer Risk

9/6/2025

28 2

Summary

Story summary

A study in Gynecologic Oncology shows BRCA1/BRCA2 mutation carriers face significant ovarian cancer risk after breast cancer.
About 5% of invasive breast cancer cases are associated with BRCA mutations, heightening ovarian cancer risk.
The research tracked 2,084 participants from 1995 to 2023, revealing a 15-year cumulative ovarian cancer risk of 10.8%.
BRCA1 carriers have a 12.2% risk, while BRCA2 carriers face a 2.0% risk.
Genetic testing at breast cancer diagnosis is vital for informed prevention and treatment choices.

1 of 1

Story summary

A study in Gynecologic Oncology shows BRCA1/BRCA2 mutation carriers face significant ovarian cancer risk after breast cancer.
About 5% of invasive breast cancer cases are associated with BRCA mutations, heightening ovarian cancer risk.
The research tracked 2,084 participants from 1995 to 2023, revealing a 15-year cumulative ovarian cancer risk of 10.8%.
BRCA1 carriers have a 12.2% risk, while BRCA2 carriers face a 2.0% risk.
Genetic testing at breast cancer diagnosis is vital for informed prevention and treatment choices.